Magellan Pharmaceutical Development is Biotechnology in United States that focus on related services business. Founded in 1991. They cover business area such as Provider, analytical testing and development service, pharmaceutical product development, pharmaceutical synthesis, clinical packaging, microbiology, biotechnology, related service, pharmaceutical and biotechnological industry.
1991
( 33 years old in 2024 )
Related Services
-
P.O. Box 13341
Durham, NC 27709
United States
Private
Provideranalytical testing and development servicepharmaceutical product developmentpharmaceutical synthesisclinical packagingmicrobiologybiotechnologyrelated servicepharmaceutical and biotechnological industry
* We use standard office opening hours in near Magellan Pharmaceutical Development's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Magellan Pharmaceutical Development is Biotechnology business from United States that founded in 1991 (33 years old in 2024), Magellan Pharmaceutical Development business is focusing on Related Services.
Magellan Pharmaceutical Development headquarter office and corporate office address is located in P.O. Box 13341 Durham, NC 27709 United States.
Magellan Pharmaceutical Development was founded in United States.
In 2024, Magellan Pharmaceutical Development is currently focus on related services sector.
Above is snippet of Google Trends for "related services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Magellan Pharmaceutical Development, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
